(Q36713856)

15 August 2017

1 reference

title

Chondroitin sulfate as a key molecule in the development of atherosclerosis and cancer progression (English)

1 reference

15 August 2017

1 reference

A D Theocharis

1

1 reference

15 August 2017

I Tsolakis

series ordinal

2

1 reference

15 August 2017

G N Tzanakakis

series ordinal

3

1 reference

15 August 2017

Nikos K Karamanos

series ordinal

4

1 reference

15 August 2017

language of work or name

1 reference

1 January 2006

1 reference

15 August 2017

published in

Advances in Pharmacology

1 reference

15 August 2017

volume

53

1 reference

15 August 2017

page(s)

281-295

1 reference

Chondroitin 4-sulphate exhibits inhibitory effect during Cu2+-mediated LDL oxidation

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Extracellular matrix in vascular morphogenesis and disease: structure versus signal

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Identification of the proteoglycan binding site in apolipoprotein B48.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Impaired elastin fiber assembly related to reduced 67-kD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Retrovirally mediated overexpression of versican v3 reverses impaired elastogenesis and heightened proliferation exhibited by fibroblasts from Costello syndrome and Hurler disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Versican interacts with chemokines and modulates cellular responses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

CD44, a cell surface chondroitin sulfate proteoglycan, mediates binding of interferon-gamma and some of its biological effects on human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Matrix proteoglycans: from molecular design to cellular function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Midkine and pleiotrophin in neural development and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Identification and characterization of ligands for L-selectin in the kidney. I. Versican, a large chondroitin sulfate proteoglycan, is a ligand for L-selectin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Oversulfated chondroitin/dermatan sulfates containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Proteoglycans: structures and interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor-related protein and LDL receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Retrovirally mediated overexpression of versican v3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

The Proteoglycan Decorin Links Low Density Lipoproteins with Collagen Type I

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Characterization of heparin affin regulatory peptide signaling in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Specificity of the low density lipoprotein-glycosaminoglycan interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Matrix proteoglycans are markedly affected in advanced laryngeal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Decreased biglycan expression and differential decorin localization in human abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

High-performance capillary electrophoretic analysis of hyaluronan and galactosaminoglycan-disaccharides in gastrointestinal carcinomas. Differential disaccharide composition as a possible tool-indicator for malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Human abdominal aortic aneurysm is closely associated with compositional and specific structural modifications at the glycosaminoglycan level

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Human abdominal aortic aneurysm is characterized by decreased versican concentration and specific downregulation of versican isoform V(0).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Compositional and structural alterations of chondroitin and dermatan sulfates during the progression of atherosclerosis and aneurysmal dilatation of the human abdominal aorta

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Involvement of stromal proteoglycans in tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Versican: a versatile extracellular matrix proteoglycan in cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Proteoglycans in atherosclerosis and restenosis: key roles for versican

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

The role of proteoglycans in cell adhesion, migration and proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953013-8

7 January 2021

10.1016/S1054-3589(05)53013-8

Identifiers

DOI

1 reference

15 August 2017

1 reference